Metabolite

Bilski seemed to get rid of mental process patents as in Metabolite.

Archive 2009-03-01 Rebecca Tushnet 2009

Gajarsa’s opinion may have inspired the United States Supreme Court to raise the subject matter issue on its own (i.e., it had not been argued by the parties to the case) in Metabolite.

Patent goo: self-replicating Paxil « Isegoria 2008

Metabolite analysis in blood and urine such as galactose-1-phosphate and sialic acid, respectively

Laboratory Rotation 2010

Classen v. Biogen: a classification of subjects in experimental group v. control group, similar to the claim in Metabolite v. Labcorp, which was about correlating individual blood test results to figure out whether there was a particular deficiency.

Archive 2009-03-01 Rebecca Tushnet 2009

The cause of the death was Metabolite Morphine or Heroin that was found in his blood stream along with high levels of alcohol.

The Russian Mob in Goa « Skid Roche 2008

The cause of the death was Metabolite Morphine or Heroin that was found in his blood stream along with high levels of alcohol.

The Russian Mob in Goa « Skid Roche 2008

Metabolite levels were significantly higher in people who reported taking at least one of four different phthalate-containing medications: mesalamine (a colitis treatment), didanosine (for HIV), omeprazole (an ulcer treatment), and theophylline (for asthma and lung disease).

More concerns about phthalates: Effects may be cumulative 2009

Metabolite on the ground that the specific argument of patent eligibility under 35 U.S.C. Section 101 had not been previously raised, claims like these are not even “at the boundary” of patent eligibility.

The Volokh Conspiracy » Mayo Collaborative Servs. v. Prometheus Laboratories, Inc. 2009

Metabolite levels were significantly higher in people who reported taking at least one of four different phthalate-containing medications: mesalamine (a colitis treatment), didanosine (for HIV), omeprazole (an ulcer treatment), and theophylline (for asthma and lung disease).

More concerns about phthalates: Effects may be cumulative 2009

Not until 2005 did the Court revisit patentable subject matter by agreeing to review Labcorp v. Metabolite, a case involving a medical diagnosis rather than software or methods.

Brian Kahin: Too Many Patents? How Patent Inflation Plagues Information Technology 2008